Title : Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A mice.

Pub. Date : 2022 Apr

PMID : 34783031






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we orally treated SOD1G93A mice with Trimetazidine, solubilized in drinking water at a dose of 20 mg/kg, from disease onset. Trimetazidine superoxide dismutase 1, soluble Mus musculus
2 KEY RESULTS: Trimetazidine administration delays motor function decline, improves muscle performance and metabolism, and significantly extends overall survival of SOD1G93A mice (increased median survival of 16 days and 12.5 days for male and female respectively). Trimetazidine superoxide dismutase 1, soluble Mus musculus
3 CONCLUSION AND IMPLICATIONS: In SOD1G93A mice, therapeutic effect of Trimetazidine is underpinned by its action on mitochondrial function in skeletal muscle and spinal cord. Trimetazidine superoxide dismutase 1, soluble Mus musculus